Strain-specific activation of the NF-κB pathway by GRA15, a novel Toxoplasma gondii dense granule protein

NF-kappa B is an integral component of the immune response to Toxoplasma gondii. Although evidence exists that T. gondii can directly modulate the NF-kappa B pathway, the parasite-derived effectors involved are unknown. We determined that type II strains of T. gondii activate more NF-kappa B than type I or type III strains, and using forward genetics we found that this difference is a result of the polymorphic protein GRA15, a novel dense granule protein which T. gondii secretes into the host cell upon invasion. A GRA15-deficient type II strain has a severe defect in both NF-kappa B nuclear translocation and NF-kappa B-mediated transcription. Furthermore, human cells expressing type II GRA15 also activate NF-kappa B, demonstrating that GRA15 alone is sufficient for NF-kappa B activation. Along with the rhoptry protein ROP16, GRA15 is responsible for a large part of the strain differences in the induction of IL-12 secretion by infected mouse macrophages. In vivo bioluminescent imaging showed that a GRA15-deficient type II strain grows faster compared with wild-type, most likely through its reduced induction of IFN-gamma. These results show for the first time that a dense granule protein can modulate host signaling pathways, and dense granule proteins can therefore join rhoptry proteins in T. gondii's host cell-modifying arsenal.